3QBQ
 
 | | Crystal structure of extracellular domains of mouse RANK-RANKL complex | | Descriptor: | Tumor necrosis factor ligand superfamily member 11, Tumor necrosis factor receptor superfamily member 11A | | Authors: | Ta, H.M, Nguyen, G.T.T, Jin, H.M, Choi, J.K, Park, H, Kim, N.S, Hwang, H.Y, Kim, K.K. | | Deposit date: | 2011-01-13 | | Release date: | 2011-03-02 | | Last modified: | 2024-10-16 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
Proc.Natl.Acad.Sci.USA, 107, 2010
|
|
8VF6
 | | Crystal structure of Serine/threonine-protein kinase 33 (STK33) Kinase Domain in complex with inhibitor CDD-2211 | | Descriptor: | Serine/threonine-protein kinase 33, {3-[([1,1'-biphenyl]-2-yl)ethynyl]-1H-indazol-5-yl}[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone | | Authors: | Ta, H.M, Kim, C, Ku, K.A, Matzuk, M.M. | | Deposit date: | 2023-12-21 | | Release date: | 2024-06-05 | | Method: | X-RAY DIFFRACTION (2.7 Å) | | Cite: | Reversible male contraception by targeted inhibition of serine/threonine kinase 33.
Science, 384, 2024
|
|
7UBO
 | | Crystal Structure of the first bromodomain of human BRDT in complex with the inhibitor CCD-956 | | Descriptor: | Bromodomain testis-specific protein, DIMETHYL SULFOXIDE, N-[(2R)-1-(methylamino)-3-{1-[(4-methyl-2-oxo-1,2-dihydroquinolin-6-yl)acetyl]piperidin-4-yl}-1-oxopropan-2-yl]-5-phenylpyridine-2-carboxamide | | Authors: | Ta, H.M, Modukuri, R.K, Yu, Z, Tan, Z, Matzuk, M.M, Kim, C. | | Deposit date: | 2022-03-15 | | Release date: | 2022-06-08 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (1.82 Å) | | Cite: | Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections.
Proc.Natl.Acad.Sci.USA, 119, 2022
|
|
5JNM
 | | Crystal structure of MtlD from Staphylococcus aureus at 1.7-Angstrom resolution | | Descriptor: | Mannitol-1-phosphate 5-dehydrogenase, SULFATE ION | | Authors: | Ta, H.M, Nguyen, T, Kim, T, Kim, K.K. | | Deposit date: | 2016-04-30 | | Release date: | 2017-11-08 | | Last modified: | 2024-10-23 | | Method: | X-RAY DIFFRACTION (1.701 Å) | | Cite: | Targeting Mannitol Metabolism as an Alternative Antimicrobial Strategy Based on the Structure-Function Study of Mannitol-1-Phosphate Dehydrogenase in Staphylococcus aureus.
Mbio, 10, 2019
|
|
9D8Z
 | | Crystal structure of the ACVR1 (ALK2) Kinase Domain in complex with inhibitor CDD-2282 | | Descriptor: | 1-[(1r,3r)-3-(methylcarbamoyl)cyclobutyl]-N-[(1-methylpiperidin-4-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1H-1,3-benzimidazole-6-carboxamide, Activin receptor type-1, PHOSPHATE ION | | Authors: | Ta, H.M, Kim, C, Jimmidi, R, Matzuk, M.M. | | Deposit date: | 2024-08-20 | | Release date: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (1.85 Å) | | Cite: | Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.
Proc.Natl.Acad.Sci.USA, 121, 2024
|
|
9D8F
 | | Crystal structure of the ACVR1 (ALK2) Kinase Domain in complex with inhibitor CDD-2281 | | Descriptor: | Activin receptor type-1, GLYCEROL, N-[3-(dimethylamino)propyl]-1-[(1r,3r)-3-(methylcarbamoyl)cyclobutyl]-2-(3,4,5-trimethoxyphenyl)-1H-1,3-benzimidazole-6-carboxamide, ... | | Authors: | Ta, H.M, Kim, C, Jimmidi, R, Matzuk, M.M. | | Deposit date: | 2024-08-19 | | Release date: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.
Proc.Natl.Acad.Sci.USA, 121, 2024
|
|
9D8E
 | | Crystal structure of the ACVR1 (ALK2) Kinase Domain in complex with inhibitor CDD-2789 | | Descriptor: | 1-cyclobutyl-N-[3-(dimethylamino)propyl]-2-(3,4,5-trimethoxyphenyl)-1H-1,3-benzimidazole-6-carboxamide, Activin receptor type-1, GLYCEROL, ... | | Authors: | Ta, H.M, Kim, C, Jimmidi, K, Matzuk, M.M. | | Deposit date: | 2024-08-19 | | Release date: | 2024-11-27 | | Method: | X-RAY DIFFRACTION (1.72 Å) | | Cite: | Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.
Proc.Natl.Acad.Sci.USA, 121, 2024
|
|
4ICS
 | | Crystal structure of PepS from Streptococcus pneumoniae in complex with a substrate | | Descriptor: | Aminopeptidase PepS, GLYCINE, TRYPTOPHAN, ... | | Authors: | Lee, S, Kim, K.K, Ta, M.H. | | Deposit date: | 2012-12-11 | | Release date: | 2013-10-23 | | Last modified: | 2024-02-28 | | Method: | X-RAY DIFFRACTION (1.97 Å) | | Cite: | Structure-based elucidation of the regulatory mechanism for aminopeptidase activity.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
4ICR
 | | Structural basis for substrate recognition and reaction mechanism of bacterial aminopeptidase peps | | Descriptor: | Aminopeptidase PepS, CACODYLATE ION, ZINC ION | | Authors: | Lee, S, Kim, K.K, Ta, M.H. | | Deposit date: | 2012-12-11 | | Release date: | 2013-10-23 | | Last modified: | 2024-02-28 | | Method: | X-RAY DIFFRACTION (2.17 Å) | | Cite: | Structure-based elucidation of the regulatory mechanism for aminopeptidase activity.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
4ICQ
 | |
